Espumisan emulsion l Menarini Treatment of abdominal and abdominal pain (30ml)
Dosage form Drinking emulsion drip
Specifications Bottle
Ingredient Simethicone
Indication Flatulence, bloating, abdominal pain
Ingredient
| Composition information | Content |
| Simethicone | 40mg/ml |
Uses
indicated
Espumisan® L contains simethicon active ingredients, is a polydimethylsiloxane operating by surface and stable mechanism. It reduces the surface tension of air bubbles surrounding food and in the mucus of the digestive tract leading to breaking air bubbles. The release vapor can be absorbed by the intestinal wall and eliminate through peristalsis.
Simethicon has no pharmacological effects, does not participate in chemical reactions and is a physiological and pharmacological substance.
Dynamic pharmacokinetics
Simethicon not absorbed by oral and unchanged excretion.
Before taking Espumisan emulsion l Menarini Treatment of abdominal and abdominal pain (30ml)
How to use
Shake well before use, to drip, slope the bottle.
Drip pills have a dose lid in ml. If necessary, the dosage division can be used for dripping, for example in the case of washing powder poisoning.
Note: To lid out of reach of children due to the danger of swallowing the lid. If the symptoms are full and/or not stop, clinical examination.
Dosage
1 ml is equivalent to 25 drops.
Symptomatic treatment of cases of gas accumulation in the digestive tract such as abdominal distention, abdominal pain in children (abdominal pain in children under 3 months old)
| 24 hours before the test date 4 - 8 ml of emulsion with each liter of contrast drug for double image quality. Before endoscopy use 4 - 8 ml. If necessary, a few ml of emulsion can be used in an endoscopy process to eliminate the influence of air bubbles. Depends on the severity of poisoning: The active ingredient Simethicon in Espumisan® L breaks down the bubbles in the gastrointestinal tract entirely according to the physical mechanism and Simethicon is a completely chemical and physiological substance. Therefore, the drug is absolutely not toxic. Even with high doses, Espumisan® L is still well tolerated without any symptoms. |
Side Effects
When using Espumisan® L often has unwanted effects (ADR).
Common, ADR> 1/100
Uncommon, 1/1000 Instructions on how to handle ADR When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
contraindicated
Espumisan® L contraindicated to patients with hypersensitivity to Simethicon or any excipients of the drug.
Be cautious when using
Patients with genetic diseases intolerant to fructose should not use Espumisan® L.
If the symptoms are full of flatulence and/or endlessly, consult a doctor to find the cause of the symptoms and the disease to be able to determine the treatment.
The ability to drive and operate machinery
does not affect the ability to drive and operate machinery.
Pregnancy
can be used for pregnant women.
Breastfeeding period
can be used for breastfeeding women.
Drug interaction
There is no drug interaction.
Storage
To be out of reach and vision of children.
Store at a temperature not exceeding 30 ° C.
Other drugs
- BETAHISTINE DIHYDROCHLORIDE 16MG TABLETS
- INFANT GRIPE WATER
- IMUNOVIR 500MG TABLETS
- KLARICID 500 MG TABLETS
- SOLPADOL 30MG/500MG CAPSULES
- ZINDACLIN 1% GEL
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions